Core Viewpoint - The article highlights the development of the world's first rapid screening test kit for tick-borne virus, which allows for quick and accurate diagnosis of the disease caused by tick bites, significantly improving patient outcomes and treatment timing [1][3]. Group 1: Product Development - The test kit, named "Quantitative Detection Kit for Fever with Thrombocytopenia Syndrome Virus," can complete qualitative and quantitative detection of viral nucleic acids within 45 minutes [1][3]. - The kit is designed to be compact, resembling the size of a palm, and integrates the functions of a traditional PCR laboratory, enhancing accessibility for rural healthcare providers [3][5]. Group 2: Technological Advancements - The sensitivity of the new test kit is reported to be 10 to 100 times higher than conventional methods, enabling detection even during the virus's latent phase when viral load is low [3][4]. - The traditional PCR method requires specialized space and equipment, while the new kit simplifies the process, allowing for individual patient testing without the need for extensive laboratory infrastructure [5]. Group 3: Clinical Impact - The rapid diagnosis capability of the test kit allows healthcare providers to make timely clinical decisions, which is crucial in managing tick-borne diseases that can progress rapidly [4][7]. - An AI model for predicting severe risk in tick-borne disease patients has been developed, which can be integrated with the test kit data to enhance patient management and triage [5][7].